<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://regulatorynews.com/tecentriq-adjuvant-dmmr-colon-cancer-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-09T10:57:15-04:00</news:publication_date>
      <news:title>FDA Approves First Adjuvant Immunotherapy for Colon Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/lipocine-verity-tlando-health-canada-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-09T09:43:18-04:00</news:publication_date>
      <news:title>Lipocine, Verity Win Health Canada Nod for TLANDO</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/perspective-therapeutics-psv359-fast-track-designation</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-09T09:43:18-04:00</news:publication_date>
      <news:title>Perspective Wins FDA Fast Track for PSV359 in Rare Sarcoma</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/zenflow-spring-series-d-cook-medical</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-09T09:43:18-04:00</news:publication_date>
      <news:title>Zenflow Lands $52M Series D, Cook Medical Distribution</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/fda-hyperoxia-monitoring-device-classification</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-09T06:02:53-04:00</news:publication_date>
      <news:title>FDA Finalizes Class II Rule for Hyperoxia Monitors</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/fda-toxicology-test-systems-510k-exemption</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-09T06:02:53-04:00</news:publication_date>
      <news:title>FDA Eases 510(k) Rule for Federal Drug-Test Devices</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/fda-tucatinib-maintenance-her2-breast-cancer</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-09T06:02:53-04:00</news:publication_date>
      <news:title>FDA Approves Tucatinib Maintenance for HER2+ Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/korjuny-catumaxomab-ascites-practice-impact</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-08T11:00:37-04:00</news:publication_date>
      <news:title>MHRA Approves First Drug for Malignant Ascites</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/optune-pax-pancreatic-cancer-practice-impact</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-08T11:00:37-04:00</news:publication_date>
      <news:title>TTFields Device Now Part of Pancreatic Cancer Care</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/mri2ct-nextmr-spine-fda-clearance</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-08T09:43:42-04:00</news:publication_date>
      <news:title>MRI2CT Clears FDA Hurdle for AI Spine Imaging</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/novocure-optune-pax-japan-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-08T09:43:42-04:00</news:publication_date>
      <news:title>Novocure Wins Japan Approval for Pancreatic Cancer Device</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/fda-herpes-claims-warning-letters</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-08T06:00:05-04:00</news:publication_date>
      <news:title>FDA Warns Amazon, Walmart Over Herpes Cream Claims</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/greenwich-rx-glutathione-recall</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-08T06:00:05-04:00</news:publication_date>
      <news:title>FDA Recall: Compounded Glutathione Tied to ED Visits</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/mhra-catumaxomab-korjuny-ascites-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-08T06:00:05-04:00</news:publication_date>
      <news:title>MHRA Approves Korjuny, a Revived Ascites Antibody</news:title>
    </news:news>
  </url>
</urlset>
